ABIVAX SA SP.ADR  EO -,01
ABIVAX SA SP.ADR EO -,01
Depository Receipt · US00370M1036 · ABVX · A3EWCP (XNMS)
Overview
6,85 EUR
0,84 % 0,06 EUR
Frankfurt (XNAS) · Current prices and charts at MoneyPeak
10.06.2025 19:59

Current Prices from ABIVAX SA SP.ADR EO -,01

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
ABVX
USD
10.06.2025 19:59
7,82 USD
7,76 USD
+0,84 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % -0,35 % 15,45 % 15,94 % -16,30 % -47,33 % -6,88 %

Company Profile for ABIVAX SA SP.ADR EO -,01 Depository Receipt

ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral remission in patients with HIV. It also develops ABX 196, an immune enhancer candidate that is in Phase 1/2 clinical trials for the treatment of hepatocellular cancer. In addition, the company engages in the research programs for the treatment of Dengue fever, influenza, and respiratory syncytial virus. ABIVAX Société Anonyme has license contracts with the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. The company was incorporated in 2013 and is headquartered in Paris, France.

Company Data

Name ABIVAX SA SP.ADR EO -,01
Company ABIVAX SA
Symbol ABVX
Website https://www.abivax.com
Primary Exchange XNMS Frankfurt
WKN A3EWCP
ISIN US00370M1036
Asset Class Depository Receipt
Sector Healthcare
Industry Biotechnology
CEO Mr. Marc M. P. de Garidel M.B.A.
Market Capitalization 397 Mio
Country France
Currency EUR
Employees 0,1 T
Address 5, rue de la Baume, 75008 Paris
IPO Date 2023-10-20

Ticker Symbols

Name Symbol
Frankfurt 2X10.F
NASDAQ ABVX

More Shares

Investors who ABIVAX SA SP.ADR EO -,01 hold also have the following shares in their portfolio:
BANK OF NOVA SCOTIA 0.65% NTS 07/04/27
BANK OF NOVA SCOTIA 0.65% NTS 07/04/27 Bond
DZ BANK      IS.25325
DZ BANK IS.25325 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025